Stockreport

Alpha Teknova Conference: TKNO Targets EBITDA Profit by 2027 as Clinical Solutions Gains Traction [Yahoo! Finance]

Alpha Teknova, Inc.  (TKNO) 
PDF is targeting to be adjusted EBITDA positive by end of 2027 once it reaches an annualized revenue run-rate of about $52–$57 million The higher-growth Clinical Solutions [Read more]